Giuliana Ferrari, Ph.D., is a full professor of Molecular Biology and Gene Expression Regulation at the San Raffaele University School of Medicine, Group leader of the Stem Cell Gene Transfer Unit and Director of GLP facility at the San Raffaele Telethon Institute for Gene Therapy in Milan.

Since the early 1990s she has pioneered the use of viral vector-mediated gene transfer techniques for the therapy of genetic diseases. Her research group has recently conducted with positive results one of the first clinical trials of gene therapy in adult and paediatric patients affected by beta-thalassemia, a genetic blood disease causing a chronic anaemia widespread in the Mediterranean area, accomplishing the clinical translation of gene therapy for beta-thalassemia.

In 2018, she received the prestigious Rosa Camuna Prize from the Regione Lombardia. In 2021, she has been nominated European Chair of the Advanced Therapy Medicinal Products (ATMP) platform at EATRIS.